文献速递胸部CTPET

PET/CT在早期肺腺癌管理中的作用

Role of PET/CT in Management of Early Lung Adenocarcinoma.
PubMed 文献 · AJR Am J Roentgenol · 2019-11-12

本研究回顾性分析IA期肺腺癌磨玻璃结节(GGN)的PET/CT数据,评估SUVmax联合高分辨率CT(HRCT)征象预测病理亚型和生长方式的效果。结果显示SUVmax在浸润性腺癌高于原位腺癌-微浸润腺癌(中位2.0 vs 1.1,p=0.008),鉴别最佳阈值为2.0;腺泡-乳头状腺癌SUVmax高于贴壁型(中位2.1 vs 1.3,p=0.037),鉴别阈值为1.4。PET/CT联合HRCT可显著提高鉴别浸润性腺癌与原位-微浸润腺癌的效能,但不能显著提高评估不同生长方式的诊断效能。

要点

  • 浸润性腺癌SUVmax高于AIS-MIA(中位2.0 vs 1.1,p=0.008),最佳鉴别阈值为2.0。
  • 腺泡-乳头状腺癌SUVmax高于贴壁型(中位2.1 vs 1.3,p=0.037),最佳鉴别阈值为1.4。
  • PET/CT联合HRCT可显著提高鉴别浸润性腺癌与AIS-MIA的效能,但对不同生长方式的评估无显著提高。

核心结论

  • FDG PET可用于预测早期肺腺癌的病理亚型和生长方式;联合HRCT对预测浸润性病理亚型有价值,但对预测浸润性生长方式无显著意义。

研究设计与样本

  • 回顾性分析IA期肺腺癌患者切除的磨玻璃结节(GGN)的PET/CT数据,评估PET最大标准化摄取值(SUVmax)联合HRCT征象预测组织病理亚型和生长方式的效能。

关键影像表现/征象

  • 具有浸润性HRCT征象的GGN中SUVmax显著更高。
  • GGN直径(比值比1.660;p=0.000)和磨玻璃成分与邻近肺组织之间的衰减值差值(比值比1.012;p=0.011)是GGN的FDG摄取的独立预测因素。

诊断标准与关键数值

  • SUVmax 2.0为鉴别浸润性腺癌与原位腺癌-微浸润腺癌(AIS-MIA)的最佳截断值。
  • SUVmax 1.4为鉴别腺癌生长方式的最佳截断值。

临床应用与阅片要点

  • 在早期肺腺癌GGN的PET/CT阅片中,可测量SUVmax辅助区分浸润性腺癌与AIS-MIA,阈值2.0。
  • SUVmax 1.4可辅助鉴别腺泡-乳头状腺癌与贴壁型腺癌的生长方式。
  • 联合HRCT可提高鉴别浸润性腺癌与AIS-MIA的效能,但对不同生长方式的评估无显著提高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this study was to explore the value of FDG PET combined with high-resolution CT (HRCT) in predicting the pathologic subtypes and growth patterns of early lung adenocarcinoma. MATERIALS AND METHODS. A retrospective analysis was conducted on the PET/CT data on ground-glass nodules (GGNs) resected from patients with stage IA lung adenocarcinoma. The efficacy of PET maximum standardized uptake value (SUVmax) combined with HRCT signs in prediction of histopathologic subtype and growth pattern of lung adeno-carcinoma was evaluated. RESULTS. SUVmax was significantly higher in GGNs with invasive HRCT signs. The diameter of GGN (odds ratio, 1.660; p = 0.000) and the difference in attenuation value (odds ratio, 1.012; p = 0.011) between ground-glass components and adjacent lung tissues were independent predictors of FDG uptake by GGNs. SUVmax was higher in invasive adenocarcinoma than in adenocarcinoma in situ (AIS)-minimally invasive adenocarcinoma (MIA) (median SUVmax, 2.0 vs 1.1; p = 0.008). An SUVmax of 2.0 was the optimal cutoff value for differentiating invasive adenocarcinoma from AIS-MIA. Acinar-papillary adenocarcinoma had a higher SUVmax than lepidic adenocarcinoma (median SUVmax, 2.1 vs 1.3; p = 0.037). An SUVmax of 1.4 was the optimal cutoff value for differentiating the growth pattern of adenocarcinoma. Use of PET/CT with HRCT significantly improved efficacy for differentiating invasive adeno-carcinoma from AIS-MIA. However, use of HRCT cannot significantly improve the diagnostic efficacy of FDG PET in the evaluation of tumors with different growth patterns. CONCLUSION. FDG PET can be used to predict the histopathologic subtypes and growth patterns of early lung adenocarcinoma. Combined with HRCT, it has value for predicting invasive histopathologic subtypes but no significance for predicting invasive growth patterns.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Shao X, Niu R, Jiang Z, et al. Role of PET/CT in Management of Early Lung Adenocarcinoma. AJR Am J Roentgenol. 2019. PMID: 31714848. doi:10.2214/AJR.19.21585

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。